FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149363162> ?p ?o ?g. }

• W2149363162 endingPage "2621" @default.
• W2149363162 startingPage "2621" @default.
• W2149363162 abstract "The effects of vitamin D3 have been investigated on various tumors, including colorectal cancer (CRC). 25-hydroxyvitamin-D3-24-hydroxylase (CYP24A1), the enzyme that inactivates the active vitamin D3 metabolite 1,25-dihydroxyvitamin D3 (1,25-D3), is considered to be the main enzyme determining the biological half-life of 1,25-D3. During colorectal carcinogenesis, the expression and concentration of CYP24A1 increases significantly, suggesting that this phenomenon could be responsible for the proposed efficacy of 1,25-D3 in the treatment of CRC. The aim of this study was to investigate the anti-tumor effects of vitamin D3 on the human CRC cell line Caco-2 after inhibition of the cytochrome P450 component of CYP24A1 activity.We examined the expression of CYP24A1 mRNA and the effects of 1,25-D3 on the cell line Caco-2 after inhibition of CYP24A1. Cell viability and proliferation were determined by means of sulforhodamine-B staining and bromodeoxyuridine incorporation, respectively, while cytotoxicity was estimated via the lactate dehydrogenase content of the cell culture supernatant. CYP24A1 expression was measured by real-time reverse transcription polymerase chain reaction. A number of tetralone compounds were synthesized to investigate their CP24A1 inhibitory activity.In response to 1,25-D3, CYP24A1 mRNA expression was enhanced significantly, in a time- and dose-dependent manner. Caco-2 cell viability and proliferation were not influenced by the administration of 1,25-D3 alone, but were markedly reduced by co-administration of 1,25-D3 and KD-35, a CYP24A1-inhibiting tetralone. Our data suggest that the mechanism of action of co-administered KD-35 and 1,25-D3 does not involve a direct cytotoxic effect, but rather the inhibition of cell proliferation.These findings demonstrate that the selective inhibition of CYP24A1 by compounds such as KD-35 may be a new approach for enhancement of the anti-tumor effect of 1,25-D3 on CRC." @default.
• W2149363162 created "2016-06-24" @default.
• W2149363162 creator A5005601386 @default.
• W2149363162 creator A5016743251 @default.
• W2149363162 creator A5022155230 @default.
• W2149363162 creator A5027029647 @default.
• W2149363162 creator A5028284301 @default.
• W2149363162 creator A5038887103 @default.
• W2149363162 creator A5047173518 @default.
• W2149363162 creator A5063605014 @default.
• W2149363162 creator A5068281424 @default.
• W2149363162 creator A5071694251 @default.
• W2149363162 creator A5079987313 @default.
• W2149363162 creator A5082117105 @default.
• W2149363162 date "2013-01-01" @default.
• W2149363162 modified "2023-10-02" @default.
• W2149363162 title "CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells" @default.
• W2149363162 cites W1573251222 @default.
• W2149363162 cites W1748624304 @default.
• W2149363162 cites W1964650555 @default.
• W2149363162 cites W1966321709 @default.
• W2149363162 cites W2001256892 @default.
• W2149363162 cites W2014193017 @default.
• W2149363162 cites W2016934755 @default.
• W2149363162 cites W2024756414 @default.
• W2149363162 cites W2026707626 @default.
• W2149363162 cites W2030751364 @default.
• W2149363162 cites W2034577630 @default.
• W2149363162 cites W2035993633 @default.
• W2149363162 cites W2040959543 @default.
• W2149363162 cites W2044294015 @default.
• W2149363162 cites W2047790964 @default.
• W2149363162 cites W2058968289 @default.
• W2149363162 cites W2059742458 @default.
• W2149363162 cites W2064148273 @default.
• W2149363162 cites W2072218698 @default.
• W2149363162 cites W2072975437 @default.
• W2149363162 cites W2074527874 @default.
• W2149363162 cites W2075910717 @default.
• W2149363162 cites W2098317434 @default.
• W2149363162 cites W2109410583 @default.
• W2149363162 cites W2109515530 @default.
• W2149363162 cites W2109901259 @default.
• W2149363162 cites W2119106302 @default.
• W2149363162 cites W2119531229 @default.
• W2149363162 cites W2124775861 @default.
• W2149363162 cites W2126617070 @default.
• W2149363162 cites W2129972919 @default.
• W2149363162 cites W2134933560 @default.
• W2149363162 cites W2135266622 @default.
• W2149363162 cites W2148285404 @default.
• W2149363162 cites W2162853148 @default.
• W2149363162 cites W2166420696 @default.
• W2149363162 cites W2169024919 @default.
• W2149363162 cites W2180102681 @default.
• W2149363162 cites W2406285770 @default.
• W2149363162 doi "https://doi.org/10.3748/wjg.v19.i17.2621" @default.
• W2149363162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3645380" @default.
• W2149363162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23674869" @default.
• W2149363162 hasPublicationYear "2013" @default.
• W2149363162 type Work @default.
• W2149363162 sameAs 2149363162 @default.
• W2149363162 citedByCount "32" @default.
• W2149363162 countsByYear W21493631622014 @default.
• W2149363162 countsByYear W21493631622015 @default.
• W2149363162 countsByYear W21493631622016 @default.
• W2149363162 countsByYear W21493631622017 @default.
• W2149363162 countsByYear W21493631622018 @default.
• W2149363162 countsByYear W21493631622019 @default.
• W2149363162 countsByYear W21493631622020 @default.
• W2149363162 countsByYear W21493631622021 @default.
• W2149363162 countsByYear W21493631622022 @default.
• W2149363162 countsByYear W21493631622023 @default.
• W2149363162 crossrefType "journal-article" @default.
• W2149363162 hasAuthorship W2149363162A5005601386 @default.
• W2149363162 hasAuthorship W2149363162A5016743251 @default.
• W2149363162 hasAuthorship W2149363162A5022155230 @default.
• W2149363162 hasAuthorship W2149363162A5027029647 @default.
• W2149363162 hasAuthorship W2149363162A5028284301 @default.
• W2149363162 hasAuthorship W2149363162A5038887103 @default.
• W2149363162 hasAuthorship W2149363162A5047173518 @default.
• W2149363162 hasAuthorship W2149363162A5063605014 @default.
• W2149363162 hasAuthorship W2149363162A5068281424 @default.
• W2149363162 hasAuthorship W2149363162A5071694251 @default.
• W2149363162 hasAuthorship W2149363162A5079987313 @default.
• W2149363162 hasAuthorship W2149363162A5082117105 @default.
• W2149363162 hasBestOaLocation W21493631621 @default.
• W2149363162 hasConcept C109316439 @default.
• W2149363162 hasConcept C121608353 @default.
• W2149363162 hasConcept C123321153 @default.
• W2149363162 hasConcept C124490489 @default.
• W2149363162 hasConcept C126322002 @default.
• W2149363162 hasConcept C1491633281 @default.
• W2149363162 hasConcept C153911025 @default.
• W2149363162 hasConcept C179639408 @default.
• W2149363162 hasConcept C185592680 @default.
• W2149363162 hasConcept C202751555 @default.
• W2149363162 hasConcept C2776074239 @default.

• next